Antibiotic Treatment for Urinary Tract Infections with Hematuria

Introduction to Hematuria in UTI Context

The American College of Radiology suggests that hematuria, either gross or microscopic, is a common presenting symptom of UTI and does not automatically classify the infection as complicated unless accompanied by other risk factors 3
The presence of blood alone, without other symptoms like fever, flank pain, or structural abnormalities, still allows treatment as an uncomplicated UTI 3
However, if gross hematuria persists after infection resolution, this warrants further urological evaluation as it may indicate underlying structural pathology 3

The American College of Cardiology is not relevant here, instead the Infectious Diseases Society of America recommends trimethoprim-sulfamethoxazole (TMP-SMX) 160/800 mg twice daily for 7 days as the preferred first-line agent for non-pregnant women 1, 2
For men, TMP-SMX 160/800 mg twice daily for 14 days is recommended as standard duration when prostatitis cannot be excluded 1, 2
Nitrofurantoin 100 mg twice daily for 5-7 days is an equally appropriate first-line alternative, particularly if TMP-SMX resistance is suspected or the patient has used TMP-SMX in the past 3 months 4

Obtain urine culture before initiating antibiotics in men, recurrent infections, or when treatment failure is suspected to guide potential therapy adjustments 1, 2, 5
Avoid fluoroquinolones as first-line therapy due to FDA warnings about disabling and serious adverse effects creating an unfavorable risk-benefit ratio for uncomplicated UTI 4, 1

If complicated UTI is suspected, empiric therapy should include ceftriaxone 2 g IV daily, fluoroquinolones (if local resistance <10%), or broader agents like piperacillin-tazobactam depending on severity 5
Risk factors for multidrug-resistant organisms include recent hospitalization, recent antibiotic use, indwelling catheter, structural urinary tract abnormalities, or immunosuppression 3, 5

E. coli shows high persistent resistance to ampicillin, amoxicillin-clavulanate, ciprofloxacin, and TMP-SMX in some cohorts 4
Nitrofurantoin maintains low resistance rates, making it a suitable option for uncomplicated lower tract infections 4
Beta-lactam antibiotics are not recommended as first-line therapy due to inferior efficacy and propensity to promote UTI recurrence 4, 1

Do not treat asymptomatic bacteriuria, as this increases risk of symptomatic infection, bacterial resistance, and healthcare costs 4, 5
Do not use fluoroquinolones empirically when other effective options are available, reserving them only for complicated infections or when local resistance to first-line agents exceeds 10% 4, 1, 2
Do not prescribe inadequate treatment duration, as this increases risk of bacteriological persistence and recurrence 1, 2

For women with diabetes, treat similarly to women without diabetes if no voiding abnormalities are present, using the same first-line agents and 7-day duration 1
Consider 14-day treatment if delayed clinical response or concern for upper tract involvement 5
For postmenopausal women, same antibiotic choices apply, but consider topical vaginal estrogen for prevention if recurrent UTIs occur with risk factors like atrophic vaginitis, urinary incontinence, or cystocele 3
After treating acute episode, consider continuous prophylaxis with TMP-SMX, nitrofurantoin, or post-coital dosing if ≥3 infections in 12 months 4, 3